From April 1, 2024 to May 30, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 836,090 shares, representing 0.42% for CNY 30.03 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.28 CNY | 0.00% |
|
+13.71% | -25.44% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.44% | 802M | |
+62.55% | 841B | |
+40.42% | 625B | |
-3.85% | 360B | |
+17.59% | 327B | |
+10.07% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+15.55% | 174B | |
+0.89% | 162B |
- Stock Market
- Equities
- 300725 Stock
- News PharmaBlock Sciences (Nanjing), Inc.
- Tranche Update on PharmaBlock Sciences, Inc.'s Equity Buyback Plan announced on October 31, 2023.